Holes in the immune system left unrepaired despite drug therapy

If they don’t receive antiretroviral therapy (ART), most HIV patients see a progressive weakening of their immune system. But a very small percentage of patients—0.3%—spontaneously control the virus themselves, without ART. Could an explanation lay partly in the sets of genes expressed by scarce white blood cells that recognize HIV? Yes, according to a study published in Nature Immunology and […]

Read more

Major tobacco companies pay almost no corporation tax despite massive profits

The world’s four major tobacco companies—two of which have HQs in the UK—are paying minimal UK corporation tax despite enormous reported profits, according to findings from new research published in the Journal of Public Health. The study, authored by researchers at the University of Bath, suggests that the UK needs far better reporting standards for corporation tax in order to […]

Read more

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine

Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to “conventional medicine”. Researchers from the Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) at the University of Technology Sydney (UTS) […]

Read more

Black women have worse breast cancer outcomes despite receiving similar treatment as white women

Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly higher breast cancer recurrence and increased overall mortality compared to white women in a large phase III clinical trial, TAILORx, according to data presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8. “Our findings are consistent with prior studies indicating that […]

Read more

FDA Approves Powerful New Opioid, Dsuvia (Sufentanil), Despite Criticisms

FRIDAY, Nov. 2, 2018 — Ruling against the recommendation of one of its chief experts, the U.S. Food and Drug Administration on Friday approved an extremely potent new opioid painkiller, Dsuvia. The drug is a 30-microgram pill that packs the same punch as 5 milligrams of intravenous morphine, according to the Washington Post. The tiny pill comes packaged in a […]

Read more